| Website | cytorex.com |
| @cytorex | |
| Category | BioTech |
| Phone | 954-573-4006 |
| Employees | 6 |
| Founded | 4/00 |
| Description | Ionic Technology For Cancer |
Cytorex Biosciences is a Florida-based Biopharma company with a patented technology (US Patent 7,1412,51) to treat cancer using an approach that has never been taken before: Inorganic Acids as actives.
Its lead compound is called Cytoreg.
Cytoreg® is a combination of 4 inorganic acids and 2 organic acids in water, where The Fluoride (F- ion) of Hydrofluoric acid is the active agent.
Cytoreg® will target and kill cancer cells without affecting normal cells, hence becoming a very effective and safe product to administer to human cancer patients.
The first indication for Cytoreg® is Glioblastoma Multiforme, a malingnant brain tumor with a very low cure rate. Cytoreg® can cross the blood brain barrier due to its very low molecular weight.
Clinical Trials ara expected to start late 2010 or early 2011 subject to funding.
